Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 18 January 2025
First Online: 29 January 2025
Declarations
:
: HS has received support for the present manuscript (to institution) and medical writing support from Daiichi Sankyo, lecture fees for Daiichi Sankyo, Chugai Pharmaceutical, and Eli Lilly, advisory role fee from Gilead Sciences. JT has received support for the present manuscript from Daiichi Sankyo (to institution), research grants from Eli Lilly, Daiichi Sankyo, and AstraZeneca (to institution), personal fees for Consulting/honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events/advisory board from Daiichi Sankyo and AstraZeneca.
